Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26


The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Fountoulakis KN, Yatham L, Grunze H, Vieta E, Young A, Blier P, Kasper S, Moeller HJ.

Int J Neuropsychopharmacol. 2017 Feb 1;20(2):121-179. doi: 10.1093/ijnp/pyw100.


The Kraepelinian Dichotomy From the Perspective of Prenatal Infectious and Immunologic Insults.

Brown AS.

Schizophr Bull. 2015 Jul;41(4):786-91. doi: 10.1093/schbul/sbv063. Epub 2015 May 11. Review.


The development and course of bipolar spectrum disorders: an integrated reward and circadian rhythm dysregulation model.

Alloy LB, Nusslock R, Boland EM.

Annu Rev Clin Psychol. 2015;11:213-50. doi: 10.1146/annurev-clinpsy-032814-112902. Epub 2015 Jan 12. Review.


Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents.

Kirino E.

Adolesc Health Med Ther. 2014 Nov 27;5:211-21. doi: 10.2147/AHMT.S50015. eCollection 2014. Review.


Almost all antipsychotics result in weight gain: a meta-analysis.

Bak M, Fransen A, Janssen J, van Os J, Drukker M.

PLoS One. 2014 Apr 24;9(4):e94112. doi: 10.1371/journal.pone.0094112. eCollection 2014.


How assess drugs in the treatment of acute bipolar mania?

Bourin M, Thibaut F.

Front Pharmacol. 2013 Jan 29;4:4. doi: 10.3389/fphar.2013.00004. eCollection 2013.


Olanzapine-induced weight gain in patients with bipolar I disorder: a meta-analysis.

Nashed MG, Restivo MR, Taylor VH.

Prim Care Companion CNS Disord. 2011;13(6). pii: PCC.11r01174. doi: 10.4088/PCC.11r01174.


Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?

Fountoulakis KN, Gonda X, Vieta E, Rihmer Z.

Ann Gen Psychiatry. 2011 Mar 24;10(1):8. doi: 10.1186/1744-859X-10-8.


Blood lactate levels in patients receiving first- or second- generation antipsychotics.

Glavina T, Mrass D, Dodig T, Glavina G, Pranić S, Uglešić B.

Croat Med J. 2011 Feb;52(1):41-7.


Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials.

Yildiz A, Vieta E, Leucht S, Baldessarini RJ.

Neuropsychopharmacology. 2011 Jan;36(2):375-89. doi: 10.1038/npp.2010.192. Epub 2010 Oct 27. Review.


Pharmaceutical treatment of acute bipolar depression.

Fountoulakis KN.

F1000 Med Rep. 2010 Jun 23;2. pii: 47. doi: 10.3410/M2-47.


Cross-species assessments of motor and exploratory behavior related to bipolar disorder.

Henry BL, Minassian A, Young JW, Paulus MP, Geyer MA, Perry W.

Neurosci Biobehav Rev. 2010 Jul;34(8):1296-306. doi: 10.1016/j.neubiorev.2010.04.002. Epub 2010 Apr 14. Review.


Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis.

Tamayo JM, Zarate CA Jr, Vieta E, Vázquez G, Tohen M.

Int J Neuropsychopharmacol. 2010 Jul;13(6):813-32. doi: 10.1017/S1461145709991246. Epub 2010 Feb 4. Review.


Treating bipolar disorder in the primary care setting: the role of aripiprazole.

Manning JS, McElroy SL.

Prim Care Companion J Clin Psychiatry. 2009;11(5):245-57. doi: 10.4088/PCC.08r00635.


Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review.

Fountoulakis KN, Vieta E.

Ann Gen Psychiatry. 2009 Jul 27;8:16. doi: 10.1186/1744-859X-8-16.


Bipolar disorder.

Geddes JR, Briess D.

BMJ Clin Evid. 2007 Aug 1;2007. pii: 1014. Review.


Review of olanzapine in the management of bipolar disorders.

Narasimhan M, Bruce TO, Masand P.

Neuropsychiatr Dis Treat. 2007;3(5):579-87.


Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder.

Nassir Ghaemi S, Shirzadi AA, Filkowski M.

Medscape J Med. 2008;10(9):211. Epub 2008 Sep 10.


Acute and long-term treatment of mania.

Vieta E, Sanchez-Moreno J.

Dialogues Clin Neurosci. 2008;10(2):165-79. Review.

Supplemental Content

Support Center